A government-backed private equity fund launched in 2018 to support high-tech industries, industrial upgrading, and innovation in the Guangdong-Hong Kong-Macao Greater Bay Area. It focuses on sectors including artificial intelligence, medical science, and financial technology, and is managed by Greater Bay Area Homeland Investments Limited.
33% of their portfolio is in Biotech & Life Sciences. Average disclosed round size is $99.4M (across 7 rounds with reported amounts).
Portfolio
9
Fund Size
—
Top Stage
Series B
Last 12 Mo
0
Team
YC
Yin Cong
Managing Director
DW
DAWEI WANG
Executive Director
JH
Jacob Hongyi Zhu
Assistant Vice President
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
Portfolio
9 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| PPudu Robotics | Series C | $77M | Sep 2021 |
 Elpiscience | Series C | $105M | May 2021 |
 ConsenSys | Unknown | $65M | Apr 2021 |
 StoneWise | Series B | — | Apr 2021 |
 Abbisko | Series D | $123M | Jan 2021 |
| 和和誉生物 | Series D | $123M | Jan 2021 |
| AAbbisko Therapeutics | Series D | $123M | Jan 2021 |
 青藤云 (Qingteng Cloud) | Series B | — | Jan 2020 |
 Ansun Biopharma | Series B | $80M | — |
Top Co-Investors
LAV4 shared
Hankang Capital3 shared
OrbiMed3 shared
Lake Bleu Capital3 shared
Warburg Pincus LLC3 shared
The Carlyle Group3 shared
Hillhouse Investment2 shared
CDH Investments2 shared
Sage2 shared
Mastercard1 shared
Protocol Labs1 shared
The LAO1 shared
JPMorgan Chase & Co.1 shared
CMT Digital1 shared
Fenbushi Capital1 shared
Meituan1 shared
HongShan1 shared
Junson Capital1 shared
3E Bioventures Capital1 shared
Last updated: 20 October 2026